Authors
Latest:
Patients Discharged From the Emergency Department After Referral for Hospitalist AdmissionHospitalization is costly and associated with the potential for adverse medical events. Hospitalists are uniquely positioned to help avoid unnecessary emergency department admissions through consultation.
Latest:
Home Care Program for Patients at High Risk of HospitalizationRandomized controlled trial of a home care program for managed care patients resulted in lower probability of hospital admission and greater patient satisfaction with care.
Latest:
Prices for Physician Services in Medicare Advantage Versus Traditional MedicareFor a set of common physician services, employer-sponsored Medicare Advantage plans are found to pay prices that are similar to traditional Medicare rates.
Latest:
Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce CostsSuccessful patient engagement in a nationally available, remotely delivered behavioral health intervention can significantly improve medical outcomes and lower healthcare costs.
Latest:
Measuring Quality in the Early Years of Health Insurance ExchangesThis article recommends quality measures for exchange health plans and strategies to increase the availability of quality results for public reporting.
Latest:
Geographic Variation in Surgical Outcomes and Cost Between the United States and JapanCompared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.
Latest:
Future Directions: Addressing Persistent Challenges in Fibrosis CarePanelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing patient-centered clinical measures, managing comorbidities, leveraging digital health tools for real-time monitoring, and addressing health equity to ensure timely, personalized care that truly reflects patients’ lived experiences.
Latest:
Clinical Outcomes and Healthcare Use Associated With Optimal ESRD StartsOptimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.
Latest:
For Payers, Cost Is the Downside of Continuing Cardiovascular Outcomes Trials in Current FormA perspective on the current FDA guidance for diabetes therapies.
Latest:
Care Fragmentation, Quality, and Costs Among Chronically Ill PatientsIncreased care fragmentation among chronically ill, commercially insured patients is associated with higher costs and lower quality of care.
Latest:
Pilot-Testing a New Program for Providing Personalized and Patient-Centered Preventive CareProgram that enhances personalized and patient-centered preventive care at a busy inner-city primary care clinic may be associated with improved health outcomes.
Latest:
Implementing an Oncology Precision Medicine Clinic in a Large Community Health SystemPrecision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.
Latest:
Disease Management Programs in Type 2 Diabetes: Quality of CareDisease management programs for diabetes can improve some processes of care, but they do not improve intermediate outcomes beyond doubt.
Latest:
Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health CentersThere is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.
Latest:
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMITThis cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
